Sign up Australia
Proactive Investors - Run By Investors For Investors

AusCann Group Holdings to reveal next medical cannabis steps in Australia

The halt will remain in place until Friday 8th December 2017.
AusCann Group Holdings to reveal next medical cannabis steps in Australia
The company's shares are in pre-open

AusCann Group Holdings Ltd (ASX:AC8) is the only listed company that is integrated across the full spectrum of the Australian medicinal cannabis supply chain.

To provide details of the next steps in its Australian operations, the ASX has granted the company a trading halt to finalise.

READ: AusCann Group Holdings secures medical cannabis cultivation licence

The halt will remain in place until the opening of trade on Friday 8th December 2017, or earlier if an announcement is made to the market.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full AC8 profile View Profile

AusCann Group Holdings Ltd Timeline

Related Articles

medical cannabis
October 01 2018
The companies will collaborate on activities to develop cannabinoid medicines as a medical option in Chile.
Laboratory testing
October 10 2018
Fifteen patients have been enrolled in the trial being carried out at Children’s Hospital of Philadelphia in the USA.
Woman holding cannabis leaf
October 16 2018
Canadian subsidiary Crystal Mountain is expanding its range of hydroponics equipment to meet expected demand.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use